APPLICATION
NDA050313
TYPE
NDA
ORIGINAL APPROVAL
1965-10-13
LATEST ACTION
1997-06-25
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Discontinued
Products
FUNGIZONEDiscontinued
AMPHOTERICIN B 3% · OINTMENT · TOPICAL
Approval history
1997-06-25Labeling · Supplement 17AP
1997-06-25Labeling · Supplement 21AP
1979-02-08Labeling · Supplement 13AP
1975-02-13Labeling · Supplement 12AP
1973-04-06Labeling · Supplement 11AP
1971-11-26Labeling · Supplement 10AP
1971-04-23Labeling · Supplement 9AP
1971-01-12Labeling · Supplement 7AP
1970-12-29Labeling · Supplement 6AP
1967-06-16Labeling · Supplement 2AP
1965-10-13UNKNOWN · Original · unknownAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.